RILP and breast cancer: To test whether RILP inhibits the invasion of breast cancer cells through inactivating RalA, GFP-RILP was co-expressed with HA-RalAwt (wild type) or HA-RalAQ72L constitutively active mutant in MDA-MB-231 cells, the cells were processed for invasion assay.